Choice of insulin in type 2 diabetes: A Southeast Asian perspective

Southeast Asia faces a diabetes epidemic, which has created significant challenges for health care. The unique Asian diabetes phenotype, coupled with peculiar lifestyle, diet, and healthcare-seeking behavior, makes it imperative to develop clinical pathways and guidelines which address local needs a...

Full description

Bibliographic Details
Main Authors: Sanjay Kalra, Hong Quang Thai, Chaicharn Deerochanawong, Goh Su-Yen, Mafauzy Mohamed, Tint Swe Latt, Than Than Aye, Zafar Ahmed Latif, Prasad Katulanda, Touch Khun, Sum Satha, Vadsana Vongvandy
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2017;volume=21;issue=3;spage=478;epage=481;aulast=Kalra
id doaj-4589b558087c4b90b5e74f6c182b4c10
record_format Article
spelling doaj-4589b558087c4b90b5e74f6c182b4c102020-11-24T22:49:21ZengWolters Kluwer Medknow PublicationsIndian Journal of Endocrinology and Metabolism2230-82102017-01-0121347848110.4103/ijem.IJEM_82_17Choice of insulin in type 2 diabetes: A Southeast Asian perspectiveSanjay KalraHong Quang ThaiChaicharn DeerochanawongGoh Su-YenMafauzy MohamedTint Swe LattThan Than AyeZafar Ahmed LatifPrasad KatulandaTouch KhunSum SathaVadsana VongvandySoutheast Asia faces a diabetes epidemic, which has created significant challenges for health care. The unique Asian diabetes phenotype, coupled with peculiar lifestyle, diet, and healthcare-seeking behavior, makes it imperative to develop clinical pathways and guidelines which address local needs and requirements. From an insulin-centric viewpoint, the preparations prescribed in such pathways should be effective, safe, well tolerated, nonintrusive, and suitable for the use in multiple clinical situations including initiation and intensification. This brief communication describes the utility of premixed or dual action insulin in such clinical pathways and guidelines.http://www.ijem.in/article.asp?issn=2230-8210;year=2017;volume=21;issue=3;spage=478;epage=481;aulast=KalraAsiabasal insulinbiphasic aspartbiphasic lisprodiabetesdual action insulinpatient-centered carepostprandial glycemiapremixed insulin
collection DOAJ
language English
format Article
sources DOAJ
author Sanjay Kalra
Hong Quang Thai
Chaicharn Deerochanawong
Goh Su-Yen
Mafauzy Mohamed
Tint Swe Latt
Than Than Aye
Zafar Ahmed Latif
Prasad Katulanda
Touch Khun
Sum Satha
Vadsana Vongvandy
spellingShingle Sanjay Kalra
Hong Quang Thai
Chaicharn Deerochanawong
Goh Su-Yen
Mafauzy Mohamed
Tint Swe Latt
Than Than Aye
Zafar Ahmed Latif
Prasad Katulanda
Touch Khun
Sum Satha
Vadsana Vongvandy
Choice of insulin in type 2 diabetes: A Southeast Asian perspective
Indian Journal of Endocrinology and Metabolism
Asia
basal insulin
biphasic aspart
biphasic lispro
diabetes
dual action insulin
patient-centered care
postprandial glycemia
premixed insulin
author_facet Sanjay Kalra
Hong Quang Thai
Chaicharn Deerochanawong
Goh Su-Yen
Mafauzy Mohamed
Tint Swe Latt
Than Than Aye
Zafar Ahmed Latif
Prasad Katulanda
Touch Khun
Sum Satha
Vadsana Vongvandy
author_sort Sanjay Kalra
title Choice of insulin in type 2 diabetes: A Southeast Asian perspective
title_short Choice of insulin in type 2 diabetes: A Southeast Asian perspective
title_full Choice of insulin in type 2 diabetes: A Southeast Asian perspective
title_fullStr Choice of insulin in type 2 diabetes: A Southeast Asian perspective
title_full_unstemmed Choice of insulin in type 2 diabetes: A Southeast Asian perspective
title_sort choice of insulin in type 2 diabetes: a southeast asian perspective
publisher Wolters Kluwer Medknow Publications
series Indian Journal of Endocrinology and Metabolism
issn 2230-8210
publishDate 2017-01-01
description Southeast Asia faces a diabetes epidemic, which has created significant challenges for health care. The unique Asian diabetes phenotype, coupled with peculiar lifestyle, diet, and healthcare-seeking behavior, makes it imperative to develop clinical pathways and guidelines which address local needs and requirements. From an insulin-centric viewpoint, the preparations prescribed in such pathways should be effective, safe, well tolerated, nonintrusive, and suitable for the use in multiple clinical situations including initiation and intensification. This brief communication describes the utility of premixed or dual action insulin in such clinical pathways and guidelines.
topic Asia
basal insulin
biphasic aspart
biphasic lispro
diabetes
dual action insulin
patient-centered care
postprandial glycemia
premixed insulin
url http://www.ijem.in/article.asp?issn=2230-8210;year=2017;volume=21;issue=3;spage=478;epage=481;aulast=Kalra
work_keys_str_mv AT sanjaykalra choiceofinsulinintype2diabetesasoutheastasianperspective
AT hongquangthai choiceofinsulinintype2diabetesasoutheastasianperspective
AT chaicharndeerochanawong choiceofinsulinintype2diabetesasoutheastasianperspective
AT gohsuyen choiceofinsulinintype2diabetesasoutheastasianperspective
AT mafauzymohamed choiceofinsulinintype2diabetesasoutheastasianperspective
AT tintswelatt choiceofinsulinintype2diabetesasoutheastasianperspective
AT thanthanaye choiceofinsulinintype2diabetesasoutheastasianperspective
AT zafarahmedlatif choiceofinsulinintype2diabetesasoutheastasianperspective
AT prasadkatulanda choiceofinsulinintype2diabetesasoutheastasianperspective
AT touchkhun choiceofinsulinintype2diabetesasoutheastasianperspective
AT sumsatha choiceofinsulinintype2diabetesasoutheastasianperspective
AT vadsanavongvandy choiceofinsulinintype2diabetesasoutheastasianperspective
_version_ 1725676107356700672